EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,930,343 | -8.2% | 3,370,506 | 0.0% | 0.53% | -4.3% |
| Q2 2023 | $29,323,402 | +195.9% | 3,370,506 | 0.0% | 0.55% | +147.3% |
| Q1 2023 | $9,909,288 | -16.0% | 3,370,506 | 0.0% | 0.22% | -6.3% |
| Q4 2022 | $11,796,771 | -55.8% | 3,370,506 | 0.0% | 0.24% | -58.0% |
| Q3 2022 | $26,660,000 | +0.5% | 3,370,506 | 0.0% | 0.57% | -19.5% |
| Q2 2022 | $26,526,000 | -35.2% | 3,370,506 | 0.0% | 0.71% | -20.9% |
| Q1 2022 | $40,952,000 | -0.7% | 3,370,506 | 0.0% | 0.89% | +23.0% |
| Q4 2021 | $41,255,000 | +79.1% | 3,370,506 | +52.5% | 0.73% | +127.9% |
| Q3 2021 | $23,033,000 | +105.0% | 2,210,506 | +76.8% | 0.32% | +77.2% |
| Q2 2021 | $11,238,000 | -11.5% | 1,250,000 | 0.0% | 0.18% | -6.2% |
| Q1 2021 | $12,700,000 | – | 1,250,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,490,921 | $27,892,459 | 24.59% |
| ACUTA CAPITAL PARTNERS, LLC | 300,128 | $2,398,023 | 1.61% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,492,147 | $27,902,255 | 1.51% |
| Cormorant Asset Management, LP | 3,200,000 | $25,568,000 | 1.49% |
| Samsara BioCapital, LLC | 432,000 | $3,451,680 | 1.06% |
| Ghost Tree Capital, LLC | 325,000 | $2,596,750 | 0.85% |
| RA Capital Management | 3,370,506 | $26,930,343 | 0.53% |
| Ikarian Capital, LLC | 4,487 | $3,585,113 | 0.43% |
| Affinity Asset Advisors, LLC | 155,000 | $1,238,450 | 0.35% |
| SECTORAL ASSET MANAGEMENT INC | 176,080 | $1,406,879 | 0.27% |